Kris P Croome
Overview
Explore the profile of Kris P Croome including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
219
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
2.
Ahmed O, Vachharajani N, Croome K, Tabrizian P, Agopian V, Halazun K, et al.
J Am Coll Surg
. 2022 Mar;
234(4):579-588.
PMID: 35290278
Background: Liver transplantation (LT) is an effective strategy for patients with unresectable hepatocellular carcinoma (HCC). To qualify for standardized LT model for end-stage liver disease exception points, the United Network...
3.
4.
Croome K, Farnell M, Que F, Reid-Lombardo K, Truty M, Nagorney D, et al.
J Gastrointest Surg
. 2014 Oct;
19(1):189-94.
PMID: 25274069
Background: Major vascular resection when necessary for margin control during pancreaticoduodenectomy is relatively universal with perioperative and oncological outcomes that are similar to those of patients undergoing a PD without...
5.
Ravichandran P, Croome K, Kovacs M, Lazo-Langner A, Hernandez-Alejandro R
Can J Gastroenterol Hepatol
. 2014 Apr;
28(4):207-11.
PMID: 24729995
Background: The optimal initial treatment of splanchnic vein thrombosis is uncertain. Anticoagulant therapy has been shown to be associated with vessel recanalization and decreased recurrence. Furthermore, information regarding potential predictors...
6.
Sela N, Croome K, Chandok N, Marotta P, Wall W, Hernandez-Alejandro R
Liver Transpl
. 2013 Aug;
19(11):1236-44.
PMID: 23913790
Liver donor characteristics have a significant impact on graft quality and, in turn, recipient outcomes. In this study, we examined deceased liver donor characteristics and donor risk index (DRI) trends...
7.
Croome K, Wall W, Chandok N, Beck G, Marotta P, Hernandez-Alejandro R
Liver Transpl
. 2013 Aug;
19(11):1214-23.
PMID: 23907778
The impact of ischemia/reperfusion injury in the setting of transplantation for hepatocellular carcinoma (HCC) has not been thoroughly investigated. The present study examined data from the Scientific Registry of Transplant...
8.
Croome K, McAlister V, Adams P, Marotta P, Wall W, Hernandez-Alejandro R
Can J Gastroenterol
. 2012 Sep;
26(9):607-10.
PMID: 22993731
Background: Previous studies have shown a higher incidence of biliary complications following donation after cardiac death (DCD) liver transplantation compared with donation after brain death (DBD) liver transplantation. The endoscopic...
9.
Hernandez-Alejandro R, Croome K, Drage M, Sela N, Parfitt J, Chandok N, et al.
World J Gastroenterol
. 2012 Aug;
18(31):4145-9.
PMID: 22919246
Aim: To compare the clinical outcome and pathologic features of non-alcoholic steatohepatitis (NASH) patients with hepatocellular carcinoma (HCC) and hepatitic C virus (HCV) patients with HCC (another group in which...
10.
Croome K, Wall W, Quan D, Vangala S, McAlister V, Marotta P, et al.
Hepatobiliary Pancreat Dis Int
. 2012 Aug;
11(4):372-6.
PMID: 22893463
Background: An updated definition of early allograft dysfunction (EAD) was recently validated in a multicenter study of 300 deceased donor liver transplant recipients. This analysis did not differentiate between donation...